160 related articles for article (PubMed ID: 4599859)
21. [The use of tobramycin in severe infections (author's transl)].
Babinet P; Bricaire F; Tancrede C; Goulon M
Sem Hop; 1978 Oct 18-25; 54(33-36):1049-54. PubMed ID: 220716
[TBL] [Abstract][Full Text] [Related]
22. Tobramycin: in vitro and clinical evaluation in 30 patients.
Perkins RL; Saslaw S; Fass RJ; Prior RB; Scholand JF; Hodges GR; Tight RR; Gardner WG
Am J Med Sci; 1976; 271(3):297-308. PubMed ID: 820196
[TBL] [Abstract][Full Text] [Related]
23. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial drugs for treatment of infections caused by aerobic gram-negative bacilli.
Boxerbaum B
Med Clin North Am; 1974 May; 58(3):519-32. PubMed ID: 4362721
[No Abstract] [Full Text] [Related]
25. Tobramycin, a new aminoglycoside antibiotic: Experience in urinary tract infections.
Landes RR; Melnick I; Hoffman A; Fehrenbaker L
South Med J; 1975 Jan; 68(1):116-7. PubMed ID: 125452
[No Abstract] [Full Text] [Related]
26. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
Gentry LO
J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
[TBL] [Abstract][Full Text] [Related]
27. Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.
Mehtar S; Drabu Y; Blakemore P
Eur J Clin Microbiol; 1986 Apr; 5(2):248-51. PubMed ID: 2941293
[No Abstract] [Full Text] [Related]
28. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
Drasar FA; Farrell W; Maskell J; Williams JD
Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
[TBL] [Abstract][Full Text] [Related]
29. [Use of new antibiotics in the treatment of infectious diseases of the urinary organs caused by gram negative bacteria].
Marshak AM; Iakovlev VP; Lur'e LA
Urol Nefrol (Mosk); 1973; 38(4):5-7. PubMed ID: 4787122
[No Abstract] [Full Text] [Related]
30. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Saavedra S; Vera D; Ramírez-Ronda CH
Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice.
Goering RV; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1978 Dec; 14(6):824-8. PubMed ID: 742870
[TBL] [Abstract][Full Text] [Related]
32. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
Noone P
Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
[TBL] [Abstract][Full Text] [Related]
33. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
Weippl G
Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
[TBL] [Abstract][Full Text] [Related]
34. Comparative non-blind trial of ceftriaxone and gentamicin in the treatment of complicated urinary tract infections.
Lentini M; Castiello G; Scorza C; Calvosa F
J Int Med Res; 1982; 10(3):166-78. PubMed ID: 6284564
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Brewer NS
Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
[TBL] [Abstract][Full Text] [Related]
36. [Aminoglycoside antibiotics from clinical viewpoint].
Lüthy R
Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):112-25. PubMed ID: 1095500
[TBL] [Abstract][Full Text] [Related]
37. Therapy of Pseudomonas aeruginosa infections with tobramycin.
Blair DC; Fekety FR; Bruce B; Silva J; Archer G
Antimicrob Agents Chemother; 1975 Jul; 8(1):22-9. PubMed ID: 809002
[TBL] [Abstract][Full Text] [Related]
38. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
[TBL] [Abstract][Full Text] [Related]
39. Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance.
Tan DT; Lee CP; Lim AS
Ann Acad Med Singap; 1995 Nov; 24(6):823-9. PubMed ID: 8838989
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of Pseudomonas aeruginosa keratitis with tobramycin and gentamicin: animal experiments (author's transl)].
Behrens-Baumann W; Paul HH; Ansorg R
Klin Monbl Augenheilkd; 1981 Mar; 178(3):197-9. PubMed ID: 7230715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
